A world where diabetic individuals no longer have to endure the frequent pain of drawing blood to measure their blood sugar. A world where thousands can be screened for diabetes without pain or fear of blood contamination. Where an accurate, easy-to-use, portable glucose meter is always at hand and the never-ending expense of blood-based testing and the biowaste it generates are eliminated. A world where painless monitoring results in more frequent testing, better disease management, fewer medical complications and lower healthcare costs.
The dream of painless, bloodless, noninvasive glucose testing is about to become a reality - with Grove Instruments™

Grove Instruments™ has developed cutting edge, patented technology that will provide a long sought alternative to the pain, inconvenience, cost and embarrassment diabetic individuals experience every day (often many times a day) with current glucose monitoring. Technology that will also allow organizations and physicians to quickly and painlessly screen people for diabetes and pre-diabetes. Numerous companies have pursued this life-altering technology through conventional spectroscopic techniques, but all have fallen well short of achieving the requisite accuracy and consistency required to replace blood-based methods.

Grove Instruments’ breakthrough Optical Bridge technology is surpassing this rigorous accuracy standard in clinical trials and moving rapidly toward final product development of its non-invasive portable blood glucose monitor and diabetes screener products for application to the FDA beginning in 2009.

Prick your finger until you bleed multiple times a day, every day, for the rest of your life? Not any more. Better diabetes control and better outcomes - achieved painlessly - with Grove Instruments™.

In October 2008 Vivascan changed
its name to Grove Instruments™. 
No changes were made in the
ownership or management
structure of the corporation.